MBRX Message Board Post 9267480 | Moleculin Biotech Inc.
home / stock / mbrx / mbrx message board
217xxx
(investorshub)
Posted on: Apr/19/2023 11:50:12
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171720612
$MBRX THIS IS GOOD >>---> As of December
News, Short Squeeze, Breakout and More Instantly...
-
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin PR Newswire Patent, once issued, will provide composition protection through 2040, with potential for additional term extension Annamycin is advancing towards pivo...
-
Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast PR Newswire HOUSTON , May 8, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceu...
-
Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data PR Newswire Annamycin in combination with Cytarabine (AnnAraC) achieves CRc rate of 62% (54% CR) in 1 st and 2 nd line AML subjects (N=13) ...